DOWNLOAD THE FREE LiSTNR APP
pharmacist

QLD Trial Enables Pharmacists To Prescribe Medication For Common Conditions

In an Australian first pharmacy trial, Queenslanders will soon have access to a number of medications without having to visit a GP. 

The statewide trial will enable pharmacists to prescribe a range of medications including the contraceptive pill, nausea medications as well as medication for skin conditions, heart disease, asthma and more. 

Stay up-to-date on the latest news with The QLD Briefing – keeping you in the loop with the region’s breaking news as it hits.

Health Minister Shannon Fentiman said the trial may help to assist with staff shortages within the medical industry.

“This nation-first pharmacy pilot is an innovative way to ensure Queenslanders have access to high-quality and cost-effective primary healthcare,” she said.

“I want all Queenslanders to benefit from innovative models of healthcare, which is why we are expanding this pilot state-wide.”

The trial follows a successful pilot which enabled pharmacists to prescribe medication for UTIs. 

RELATED:   Small Plane Executes Emergency Belly Landing At Newcastle Airport

“The UTI Pharmacy Pilot and international evidence shows that allowing pharmacists to prescribe for common conditions is a safe and efficient way to improve health outcomes,” Ms Fentiman said. 

“Pharmacists are highly trained and regulated healthcare professionals, and this pilot will ensure their expertise is used to its full scope.

“Pharmacy prescribing models of care are used effectively in other countries, including the United Kingdom, Canada and New Zealand.

“This will also help address the impacts of workforce shortages and distribution problems, particularly in regional and rural communities.”

The trial is set to take place over 2024 and 2025 with the search for participating pharmacists to begin in 2023. 

Subscribe to The Briefing, Australia’s fastest-growing news podcast on Listnr today. The Briefing serves up the latest news headlines and a deep dive into a topic affecting you. All in under 20 minutes.